A detailed history of Kidder Stephen W transactions in Abb Vie Inc. stock. As of the latest transaction made, Kidder Stephen W holds 13,326 shares of ABBV stock, worth $2.23 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares
13,326
Previous 14,126 5.66%
Holding current value
$2.23 Million
Previous $2.19 Million 10.83%
% of portfolio
0.78%
Previous 0.71%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $127,856 - $145,680
-800 Reduced 5.66%
13,326 $2.43 Million
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $51,049 - $57,493
-371 Reduced 2.56%
14,126 $2.19 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $62,787 - $72,685
-470 Reduced 3.14%
14,497 $2.16 Million
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $67,315 - $83,769
-508 Reduced 3.28%
14,967 $2.02 Million
Q1 2023

May 10, 2023

SELL
$144.61 - $166.54 $85,319 - $98,258
-590 Reduced 3.67%
15,475 $2.47 Million
Q4 2022

Feb 09, 2023

BUY
$138.31 - $165.87 $330,560 - $396,429
2,390 Added 17.48%
16,065 $2.6 Million
Q3 2022

Nov 08, 2022

SELL
$134.21 - $153.93 $35,565 - $40,791
-265 Reduced 1.9%
13,675 $1.84 Million
Q2 2022

Jul 19, 2022

SELL
$137.62 - $174.96 $216,751 - $275,562
-1,575 Reduced 10.15%
13,940 $2.14 Million
Q1 2022

May 17, 2022

SELL
$131.98 - $163.75 $76,812 - $95,302
-582 Reduced 3.62%
15,515 $2.52 Million
Q4 2021

Feb 08, 2022

SELL
$107.43 - $135.93 $447,768 - $566,556
-4,168 Reduced 20.57%
16,097 $2.18 Million
Q3 2021

Nov 10, 2021

SELL
$106.4 - $120.78 $4,788 - $5,435
-45 Reduced 0.22%
20,265 $2.19 Million
Q2 2021

Aug 09, 2021

BUY
$105.21 - $117.21 $138,351 - $154,131
1,315 Added 6.92%
20,310 $2.29 Million
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $21,483 - $23,650
-210 Reduced 1.09%
18,995 $2.06 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $201,225 - $271,675
-2,500 Reduced 11.52%
19,205 $2.06 Million
Q3 2020

Oct 28, 2020

SELL
$85.91 - $100.83 $8,591 - $10,083
-100 Reduced 0.46%
21,705 $1.9 Million
Q2 2020

Jul 28, 2020

SELL
$73.37 - $98.18 $45,416 - $60,773
-619 Reduced 2.76%
21,805 $2.14 Million
Q1 2020

May 07, 2020

SELL
$64.5 - $97.79 $14,512 - $22,002
-225 Reduced 0.99%
22,424 $1.71 Million
Q4 2019

Jan 15, 2020

SELL
$72.13 - $90.25 $3,606 - $4,512
-50 Reduced 0.22%
22,649 $2 Million
Q3 2019

Nov 07, 2019

BUY
$62.98 - $75.72 $22,987 - $27,637
365 Added 1.63%
22,699 $1.72 Million
Q2 2019

Jul 24, 2019

SELL
$65.7 - $83.98 $4,861 - $6,214
-74 Reduced 0.33%
22,334 $1.62 Million
Q1 2019

May 01, 2019

SELL
$77.14 - $90.79 $566,979 - $667,306
-7,350 Reduced 24.7%
22,408 $1.81 Million
Q4 2018

Jan 24, 2019

SELL
$77.85 - $96.01 $149,082 - $183,859
-1,915 Reduced 6.05%
29,758 $2.74 Million
Q3 2018

Oct 15, 2018

SELL
$88.91 - $98.84 $20,893 - $23,227
-235 Reduced 0.74%
31,673 $3 Million
Q2 2018

Jul 30, 2018

SELL
$89.78 - $106.23 $99,655 - $117,915
-1,110 Reduced 3.36%
31,908 $2.96 Million
Q1 2018

Apr 24, 2018

SELL
$92.01 - $123.21 $356,078 - $476,822
-3,870 Reduced 10.49%
33,018 $3.13 Million
Q4 2017

Feb 02, 2018

SELL
$89.56 - $98.21 $74,782 - $82,005
-835 Reduced 2.21%
36,888 $3.57 Million
Q3 2017

Oct 26, 2017

BUY
$69.85 - $89.22 $2.63 Million - $3.37 Million
37,723
37,723 $3.35 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $296B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Kidder Stephen W Portfolio

Follow Kidder Stephen W and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kidder Stephen W, based on Form 13F filings with the SEC.

News

Stay updated on Kidder Stephen W with notifications on news.